Literature DB >> 21510545

Minimally invasive oesophagectomy for carcinoma oesophagus--approaches and options in a high volume tertiary centre.

P S Rajan1, V Vaithiswaran, S Rajapandian, P Senthilnathan, P Praveenraj, C Palanivelu.   

Abstract

Minimally invasive oesophagectomy is being increasingly performed for treatment of carcinoma oesophagus. In this article, we overview the different types of minimally invasive oesophagectomies we used in our experience. To present an overview of the different types of minimally invasive oesophagectomies used to treat carcinoma oesophagus and to propose a simple working algorithm for surgical management of carcinoma oesophagus, a retrospective review of patients with carcinoma oesophagus who were operated at this centre during the period 1997-2009 was made. Data regarding type of surgery, level of growth, type of carcinoma, and complications were reviewed. A total of 463 patients underwent minimally invasive oesophagectomy for carcinoma oesophagus. Of these, 121 patients (26%) were female. There were no conversions. The mean age of patients was 61.6 years (range 36 years-77 years). Most patients (n = 330; 71%) had squamous cell carcinoma while 133 patients (29%) had adenocarcinoma. Overall mortality was 0.9%. Overall morbidity was 16%. Minimally invasive approaches to oesophagectomy are safe and the type of approach has to be tailored for the histology, level and stage of growth.

Entities:  

Mesh:

Year:  2010        PMID: 21510545

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  8 in total

1.  Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy.

Authors:  Pragatheeshwar Thirunavukarasu; Emmanuel Gabriel; Kristopher Attwood; Moshim Kukar; Steven N Hochwald; Steven J Nurkin
Journal:  Int J Surg       Date:  2015-11-18       Impact factor: 6.071

Review 2.  Minimally invasive oesophagectomy versus open surgery: is there an advantage?

Authors:  Lesley Uttley; Fiona Campbell; Michael Rhodes; Anna Cantrell; Heather Stegenga; Myfanwy Lloyd-Jones
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

3.  McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis.

Authors:  Frans van Workum; Gijs H Berkelmans; Bastiaan R Klarenbeek; Grard A P Nieuwenhuijzen; Misha D P Luyer; Camiel Rosman
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Impact of minimally invasive surgery in the treatment of esophageal cancer.

Authors:  M Italo Braghetto; H Gonzalo Cardemil; B Carlos Mandiola; L Gonzalo Masia; S Francesca Gattini
Journal:  Arq Bras Cir Dig       Date:  2014 Nov-Dec

Review 5.  Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer: a systematic review and meta-analysis.

Authors:  Jianqing Deng; Qingqing Su; Zhipeng Ren; Jiaxin Wen; Zhiqiang Xue; Lianbin Zhang; Xiangyang Chu
Journal:  Onco Targets Ther       Date:  2018-09-20       Impact factor: 4.147

6.  Robotic-assisted minimally invasive oesophagectomy for cancer: An initial experience.

Authors:  Chinnusamy Palanivelu; Sumanta Dey; Sandeep Sabnis; Raghavendra Gupta; Bharath Cumar; Saravana Kumar; Ramesh Natarajan; Parthasarathi Ramakrishnan
Journal:  J Minim Access Surg       Date:  2019 Jul-Sep       Impact factor: 1.407

7.  Non-placement versus placement of a drainage tube around the cervical anastomosis in McKeown esophagectomy: study protocol for a randomized controlled trial.

Authors:  Taro Oshikiri; Gosuke Takiguchi; Susumu Miura; Nobuhisa Takase; Hiroshi Hasegawa; Masashi Yamamoto; Shingo Kanaji; Kimihiro Yamashita; Yoshiko Matsuda; Takeru Matsuda; Tetsu Nakamura; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Trials       Date:  2019-12-23       Impact factor: 2.279

8.  Review of minimally invasive esophagectomy and current controversies.

Authors:  T Kim; S N Hochwald; G A Sarosi; A M Caban; G Rossidis; K Ben-David
Journal:  Gastroenterol Res Pract       Date:  2012-08-02       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.